Growth Hormone Promotes Lipolysis and Impairs Insulin Sensitivity by Activating the ERK/HSL Signaling Pathway in Bovine Adipocytes

Abstract

The physiological adaptation responses of peripartum cows to negative energy balance, including fat mobilization and insulin resistance, are controlled by hormones. Excessive growth hormone (GH) promotes fat mass loss and insulin resistance in nonruminants. Despite elevated circulating GH in postpartum cows, its regulatory mechanisms on lipid metabolism and insulin signaling pathways in bovine adipocytes remain unresolved. This research study intends to examine the effects that GH has on lipolysis and insulin sensitivity within bovine adipocytes and provide mechanistic insights. We discovered that GH stimulates lipolysis and compromised insulin sensitivity, as evidenced by elevated glycerol release, reduced triglyceride accumulation, and diminished lipid droplet formation, along with impaired insulin-mediated phosphorylation of protein kinase B (AKT) in GH-treated adipocytes. The combination of GH and isoproterenol exacerbated the insulin insensitivity and lipolysis induced by GH. Phosphorylation levels of ERK and HSL were elevated in adipocytes treated with GH, suggesting that GH activated the ERK/HSL signaling pathway. The mRNA abundance of cell death-inducing DNA fragmentation factor-α-like effector c and perilipin 1 was downregulated by GH in adipocytes. Importantly, inhibiting ERK and HSL (hormone sensitive lipase; encoded by LIPE) attenuated GH-induced lipolysis and insulin insensitivity. Collectively, GH enhances lipolysis and impairs insulin sensitivity in bovine adipocytes via activating the ERK/HSL signaling pathway at least partially. Therefore, inhibiting the ERK/HSL signaling pathway may be a promising means to avoid excessive fat mobilization and insulin resistance in dairy cows during the peripartum period.

Keywords

adipocytes / dairy cow / growth hormone / insulin resistance / lipid mobilization

References

[1] K. E. Mills, D. M. Weary, and M. A. G. Von Keyserlingk, “Identifying Barriers to Successful Dairy Cow Transition Management,” Journal of Dairy Science 103, no. 2 (2020): 1749–1758, https://doi.org/10.3168/jds.2018-16231.

[2] W. Xu, A. Van Knegsel, E. Saccenti, R. Van Hoeij, B. Kemp, and J. Vervoort, “Metabolomics of Milk Reflects a Negative Energy Balance in Cows,” Journal of Proteome Research 19, no. 8 (2020): 2942–2949, https://doi.org/10.1021/acs.jproteome.9b00706.

[3] T. H. Swartz, U. Moallem, H. Kamer, et al., “Characterization of the Liver Proteome in Dairy Cows Experiencing Negative Energy Balance at Early Lactation,” Journal of Proteomics 246 (2021): 104308, https://doi.org/10.1016/j.jprot.2021.104308.

[4] L. Ju, Q. Shao, Z. Fang, et al., “Dietary Supplementation With Citrus Peel Extract in Transition Period Improves Rumen Microbial Composition and Ameliorates Energy Metabolism and Lactation Performance of Dairy Cows,” Journal of Animal Science and Biotechnology 15, no. 1 (2024): 152–165, https://doi.org/10.1186/s40104-024-01110-8.

[5] G. A. Contreras and L. M. Sordillo, “Lipid Mobilization and Inflammatory Responses During the Transition Period of Dairy Cows,” Comparative Immunology, Microbiology and Infectious Diseases 34, no. 3 (2011): 281–289, https://doi.org/10.1016/j.cimid.2011.01.004.

[6] F. Zhang, X. Nan, H. Wang, Y. Zhao, Y. Guo, and B. Xiong, “Effects of Propylene Glycol on Negative Energy Balance of Postpartum Dairy Cows,” Animals 10, no. 9 (2020): 1526–1540, https://doi.org/10.3390/ani10091526.

[7] M. N. Myers, M. Chirivi, J. C. Gandy, J. Tam, M. Zachut, and G. A. Contreras, “Lipolysis Pathways Modulate Lipid Mediator Release and Endocannabinoid System Signaling in Dairy Cows Adipocytes,” Journal of Animal Science and Biotechnology 15, no. 1 (2024): 103–119, https://doi.org/10.1186/s40104-024-01062-z.

[8] J. D. De Koster and G. Opsomer, “Insulin Resistance in Dairy Cows,” Veterinary Clinics of North America: Food Animal Practice 29, no. 2 (2013): 299–322, https://doi.org/10.1016/j.cvfa.2013.04.002.

[9] B. A. Corl, S. T. Butler, W. R. Butler, and D. E. Bauman, “Short Communication: Regulation of Milk Fat Yield and Fatty Acid Composition by Insulin,” Journal of Dairy Science 89, no. 11 (2006): 4172–4175, https://doi.org/10.3168/jds.s0022-0302(06)72462-6.

[10] R. E. Duncan, M. Ahmadian, K. Jaworski, E. Sarkadi-Nagy, and H. S. Sul, “Regulation of Lipolysis in Adipocytes,” Annual Review of Nutrition 27, no. 1 (2007): 79–101, https://doi.org/10.1146/annurev.nutr.27.061406.093734.

[11] N. Møller and J. O. Jørgensen, “Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects,” Endocrine Reviews 30, no. 2 (2009): 152–177, https://doi.org/10.1210/er.2008-0027.

[12] V. M. Sharma, “Emerging Mechanisms of GH-Induced Lipolysis and Insulin Resistance,” Pediatric Endocrinology Reviews 17 (2019): 4–16.

[13] J. Huang, S. Siyar, R. Sharma, et al., “Adipocyte Subpopulations Mediate Growth Hormone-Induced Lipolysis and Glucose Tolerance in Male Mice,” Endocrinology 164, no. 11 (2023): bqad151, https://doi.org/10.1210/endocr/bqad151.

[14] F. P. Dominici and D. Turyn, “Growth Hormone-Induced Alterations in the Insulin-Signaling System,” Experimental Biology and Medicine 227, no. 3 (2002): 149–157, https://doi.org/10.1177/153537020222700301.

[15] S. Blüher, J. Kratzsch, and W. Kiess, “Insulin-Like Growth Factor I, Growth Hormone and Insulin in White Adipose Tissue,” Best Practice & Research Clinical Endocrinology & Metabolism 19, no. 4 (2005): 577–587, https://doi.org/10.1016/j.beem.2005.07.011.

[16] G. Wang, Y. Zhu, D. Feng, J. Yao, Y. Cao, and L. Deng, “Hepatic Gluconeogenesis and Regulatory Mechanisms in Lactating Ruminants: A Literature Review,” Animal Research and One Health (2024): 1–10, https://doi.org/10.1002/aro2.80.

[17] M. A. Mohsin, H. Yu, R. He, et al., “Differentiation of Subclinical Ketosis and Liver Function Test Indices in Adipose Tissues Associated With Hyperketonemia in Postpartum Dairy Cattle, Frontiers in Veterinary Science 8 (2021): 796494, https://doi.org/10.3389/fvets.2021.796494.

[18] M. Lafontan and D. Langin, “Lipolysis and Lipid Mobilization in Human Adipose Tissue,” Progress in Lipid Research 48, no. 5 (2009): 275–297, https://doi.org/10.1016/j.plipres.2009.05.001.

[19] G. Frühbeck, L. Méndez-Giménez, J. A. Fernández-Formoso, S. Fernández, and A. Rodríguez, “Regulation of Adipocyte Lipolysis,” Nutrition Research Reviews 27, no. 1 (2014): 63–93, https://doi.org/10.1017/s095442241400002x.

[20] H. E. Bergan, J. D. Kittilson, and M. A. Sheridan, “PKC and ERK Mediate GH-Stimulated Lipolysis,” Journal of Molecular Endocrinology 51, no. 2 (2013): 213–224, https://doi.org/10.1530/jme-13-0039.

[21] V. M. Sharma, E. T. Vestergaard, N. Jessen, et al., “Growth Hormone Acts Along the PPARγ-FSP27 Axis to Stimulate Lipolysis in Human Adipocytes,” American Journal of Physiology. Endocrinology and Metabolism 316, no. 1 (2019): 34–42, https://doi.org/10.1152/ajpendo.00129.2018.

[22] A. Girousse, G. Tavernier, C. Valle, et al., “Partial Inhibition of Adipose Tissue Lipolysis Improves Glucose Metabolism and Insulin Sensitivity Without Alteration of Fat Mass,” PLoS Biology 11, no. 2 (2013): e1001485, https://doi.org/10.1371/journal.pbio.1001485.

[23] J. Zong, S. Li, Y. Wang, W. Mo, R. Sun, and M. Yu, “Bromodomain-Containing Protein 2 Promotes Lipolysis Via ERK/HSL Signalling Pathway in White Adipose Tissue of Mice,” General and Comparative Endocrinology 281 (2019): 105–116, https://doi.org/10.1016/j.ygcen.2019.05.011.

[24] T. Zhu, L. Ling, and P. E. Lobie, “Identification of a JAK2-Independent Pathway Regulating Growth Hormone (GH)-Stimulated P44/42 Mitogen-Activated Protein Kinase Activity. GH Activation of Ral and Phospholipase D Is Src-Dependent,” Journal of Biological Chemistry 277, no. 47 (2002): 45592–45603, https://doi.org/10.1074/jbc.m201385200.

[25] N. J. Lanning and C. Carter-Su, “Recent Advances in Growth Hormone Signaling,” Reviews in Endocrine & Metabolic Disorders 7, no. 4 (2006): 225–235, https://doi.org/10.1007/s11154-007-9025-5.

[26] S. W. Rowlinson, H. Yoshizato, J. L. Barclay, et al., “An Agonist-Induced Conformational Change in the Growth Hormone Receptor Determines the Choice of Signalling Pathway,” Nature Cell Biology 10, no. 6 (2008): 740–747, https://doi.org/10.1038/ncb1737.

[27] H. Yu, X. Gao, J. J. Loor, et al., “Activation of Transcription Factor EB Is Associated With Adipose Tissue Lipolysis in Dairy Cows With Subclinical Ketosis,” Frontiers in Veterinary Science 9 (2022): 816064, https://doi.org/10.3389/fvets.2022.816064.

[28] X. Du, M. Liu, W. Tai, et al., “Tumor Necrosis Factor-α Promotes Lipolysis and Reduces Insulin Sensitivity by Activating Nuclear Factor Kappa B and C-Jun N-Terminal Kinase in Primary Bovine Adipocytes,” Journal of Dairy Science 105, no. 10 (2022): 8426–8438, https://doi.org/10.3168/jds.2022-22009.

[29] H. Yu, M. Fan, X. Chen, et al., “Activated Autophagy-Lysosomal Pathway in Dairy Cows With Hyperketonemia Is Associated With Lipolysis of Adipose Tissues,” Journal of Dairy Science 105, no. 8 (2022): 6997–7010, https://doi.org/10.3168/jds.2021-21287.

[30] Y. Li, H. Ding, L. Liu, et al., “Non-Esterified Fatty Acid Induce Dairy Cow Hepatocytes Apoptosis Via the Mitochondria-Mediated ROS-JNK/ERK Signaling Pathway,” Frontiers in Cell and Developmental Biology 28 (2020): 245–258, https://doi.org/10.3389/fcell.2020.00245.

[31] L. H. Zeng, C. Tang, M. Yao, et al., “Phosphorylation of Human Glioma-Associated Oncogene 1 on Ser937 Regulates Sonic Hedgehog Signaling in Medulloblastoma,” Nature Communications 15 (2024): 987–998, https://doi.org/10.1038/s41467-024-45315-x.

[32] X. Du, Y. Zhu, Z. Peng, et al., “High Concentrations of Fatty Acids and β-hydroxybutyrate Impair the Growth Hormone-Mediated Hepatic JAK2-STAT5 Pathway in Clinically Ketotic Cows,” Journal of Dairy Science 101, no. 4 (2018): 3476–3487, https://doi.org/10.3168/jds.2017-13234.

[33] M. A. Mohsin, X. Zhou, Y. Huiru, et al., “Effects of Higher Plasma Growth Hormone Levels on Subclinical Ketosis in Postpartum Holstein Cows,” Annals of Animal Science 22, no. 4 (2022): 1265–1272, https://doi.org/10.2478/aoas-2022-0034.

[34] A. Raux, E. Bichon, A. Benedetto, et al., “The Promise and Challenges of Determining Recombinant Bovine Growth Hormone in Milk,” Foods 11, no. 3 (2022): 274–286, https://doi.org/10.3390/foods11030274.

[35] Z. Fang, Y. Xu, G. Liu, et al., “Narirutin Activates TFEB (Transcription Factor EB) to Protect Against Acetaminophen-Induced Liver Injury by Targeting PPP3/Calcineurin,” Autophagy 19, no. 8 (2023): 2240-2256, https://doi.org/10.1080/15548627.2023.2179781.

[36] M. Chen, G. Liu, Z. Fang, et al., “Buddleoside Alleviates Nonalcoholic Steatohepatitis by Targeting the AMPK-TFEB Signaling Pathway,” Autophagy 16 (2025): 1–19, https://doi.org/10.1080/15548627.2025.2466145.

[37] L. H. Baumgard, R. J. Collier, and D. E. Bauman, “A 100-Year Review: Regulation of Nutrient Partitioning to Support Lactation,” Journal of Dairy Science 100, no. 12 (2017): 10353–10366, https://doi.org/10.3168/jds.2017-13242.

[38] P. Karis, H. Jaakson, K. Ling, et al., “Body Condition and Insulin Resistance Interactions With Periparturient Gene Expression in Adipose Tissue and Lipid Metabolism in Dairy Cows,” Journal of Dairy Science 103, no. 4 (2020): 3708–3718, https://doi.org/10.3168/jds.2019-17373.

[39] D. E. Bauman and R. G. Vernon, “Effects of Exogenous Bovine Somatotropin on Lactation,” Annual Review of Nutrition 13, no. 1 (1993): 437–461, https://doi.org/10.1146/annurev.nu.13.070193.002253.

[40] M. P. Faylon, D. E. Koltes, and D. M. Spurlock, “Regulation of Lipid Droplet-Associated Proteins Following Growth Hormone Administration and Feed Restriction in Lactating Holstein Cows,” Journal of Dairy Science 97, no. 5 (2014): 2847–2855, https://doi.org/10.3168/jds.2013-7565.

[41] R. P. Radcliff, B. L. McCormack, B. A. Crooker, and M. C. Lucy, “Plasma Hormones and Expression of Growth Hormone Receptor and Insulin-Like Growth Factor-I mRNA in Hepatic Tissue of Periparturient Dairy Cows,” Journal of Dairy Science 86, no. 12 (2003): 3920–3926, https://doi.org/10.3168/jds.s0022-0302(03)74000-4.

[42] K. L. Høyer, M. L. Høgild, E. O. List, et al., “The Acute Effects of Growth Hormone in Adipose Tissue Is Associated With Suppression of Antilipolytic Signals,” Physiological Reports 8, no. 3 (2020): e14373, https://doi.org/10.14814/phy2.14373.

[43] C. Nielsen, L. C. Gormsen, N. Jessen, et al., “Growth Hormone Signaling In Vivo in Human Muscle and Adipose Tissue: Impact of Insulin, Substrate Background, and Growth Hormone Receptor Blockade,” Journal of Cinical Endocrinology and Metabolism 93, no. 7 (2008): 2842–2850, https://doi.org/10.1210/jc.2007-2414.

[44] J. J. Kopchick, D. E. Berryman, V. Puri, K. Y. Lee, and J. O. L. Jorgensen, “The Effects of Growth Hormone on Adipose Tissue: Old Observations, New Mechanisms,” Nature Reviews Endocrinology 16, no. 3 (2020): 135–146, https://doi.org/10.1038/s41574-019-0280-9.

[45] J. P. Del Rincon, K. Iida, B. D. Gaylinn, et al., “Growth Hormone Regulation of P85 Alpha Expression and Phosphoinositide 3-Kinase Activity in Adipose Tissue: Mechanism for Growth Hormone-Mediated Insulin Resistance,” Diabetes 56, no. 6 (2007): 1638–1646, https://doi.org/10.2337/db06-0299.

[46] M. C. Lucy, H. Jiang, and Y. Kobayashi, “Changes in the Somatotrophic Axis Associated With the Initiation of Lactation,” Journal of Dairy Science 84 (2001): 113–119, https://doi.org/10.3168/jds.s0022-0302(01)70205-6.

[47] P. R. B. Silva, W. J. Weber, B. A. Crooker, R. J. Collier, W. W. Thatcher, and R. C. Chebel, “Hepatic mRNA Expression for Genes Related to Somatotropic Axis, Glucose and Lipid Metabolisms, and Inflammatory Response of Periparturient Dairy Cows Treated With Recombinant Bovine Somatotropin,” Journal of Dairy Science 100, no. 5 (2017): 3983–3999, https://doi.org/10.3168/jds.2016-12135.

[48] A. Takano, T. Haruta, M. Iwata, et al., “Growth Hormone Induces Cellular Insulin Resistance by Uncoupling Phosphatidylinositol 3-Kinase and Its Downstream Signals in 3T3-L1 Adipocytes,” Diabetes 50, no. 8 (2001): 1891–1900, https://doi.org/10.2337/diabetes.50.8.1891.

[49] S. Nielsen, N. Møller, J. S. Christiansen, and J. O. Jørgensen, “Pharmacological Antilipolysis Restores Insulin Sensitivity During Growth Hormone Exposure,” Diabetes 50, no. 10 (2001): 2301–2308, https://doi.org/10.2337/diabetes.50.10.2301.

[50] K. C. Corbit, J. P. G. Camporez, J. L. Tran, et al., “Adipocyte JAK2 Mediates Growth Hormone-Induced Hepatic Insulin Resistance,” JCI Insight 2, no. 3 (2017): e91001, https://doi.org/10.1172/jci.insight.91001.

[51] A. Chalmeh, M. Pourjafar, S. Nazifi, F. Momenifar, and M. Mohamadi, “Insulin Resistance in Different Physiological States of High Producing Holstein Dairy Cows,” Acta Scientiae Veterinariae 43 (2015): 1–7.

[52] D. R. Barayan, C. Vinaik, C. Auger, M. Knuth, A. Abdullahi, and M. G. Jeschke, “Inhibition of Lipolysis With Acipimox Attenuates Postburn White Adipose Tissue Browning and Hepatic Fat Infiltration,” Shock 53, no. 2 (2020): 137–145, https://doi.org/10.1097/shk.0000000000001439.

[53] A. J. Brooks and M. J. Waters, “The Growth Hormone Receptor: Mechanism of Activation and Clinical Implications,” Nature Reviews Endocrinology 6, no. 9 (2010): 515–525, https://doi.org/10.1038/nrendo.2010.123.

[54] J. Dietz and J. Schwartz, “Growth Hormone Alters Lipolysis and Hormone-Sensitive Lipase Activity in 3T3-F442A Adipocytes,” Metabolism 40, no. 8 (1991): 800–806, https://doi.org/10.1016/0026-0495(91)90006-i.

[55] R. Sharma, Q. Luong, V. M. Sharma, et al., “Growth Hormone Controls Lipolysis by Regulation of FSP27 Expression,” Journal of Endocrinology 239, no. 3 (2018): 289–301, https://doi.org/10.1530/joe-18-0282.

[56] B. Salgin, M. L. Marcovecchio, R. M. Williams, et al., “Effects of Growth Hormone and Free Fatty Acids on Insulin Sensitivity in Patients With Type 1 Diabetes,” Journal of Cinical Endocrinology and Metabolism 94, no. 9 (2009): 3297–3305, https://doi.org/10.1210/jc.2009-0378.

[57] A. Girousse and D. Langin, “Adipocyte Lipases and Lipid Droplet-Associated Proteins: Insight From Transgenic Mouse Models,” International Journal of Obesity 36, no. 4 (2012): 581–594, https://doi.org/10.1038/ijo.2011.113.

RIGHTS & PERMISSIONS

2025 The Author(s). Animal Research and One Health published by John Wiley & Sons Australia, Ltd on behalf of Institute of Animal Science, Chinese Academy of Agricultural Sciences.